Low Grade Astrocytoma — Trials

Low Grade Astrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

70 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03528642	Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma	active not recruiting	Phase 1	23	National Cancer Institute (NCI)NIH	1	Sep 22, 2026	clinicaltrials
NCT01089101	Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma	active not recruiting	Phase 1 / Phase 2	217	National Cancer Institute (NCI)NIH	1	Sep 21, 2026